LNTH
Lantheus Holdings, Inc.
+0.39 (+0.39%)100.93USD86.4K成交股數6.6B市值24.1本益比(近四季)4.2股價營收比+2.7%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 388M+3% | 377M+1% | 407M+7% | 384M-3% | 378M+2% | 373M+5% | 379M+18% | 394M+23% | 370M | 354M | 320M | 322M |
| 營業成本 | 146M | 146M | 166M | 162M | 137M | 135M | 137M | 138M | 128M | 124M | 120M | 119M |
| 毛利 | 242M+0% | 231M-3% | 241M-1% | 222M-13% | 241M-0% | 238M+3% | 242M+21% | 256M+26% | 242M | 230M | 200M | 203M |
| 毛利率 | 62.3% | 61.2% | 59.2% | 57.9% | 63.8% | 63.8% | 63.9% | 64.9% | 65.4% | 64.9% | 62.5% | 63.0% |
| 研發費用 | 38.2M | 39.4M | 47.5M | 48.0M | 45.5M | 36.3M | 24.1M | 60.6M | 48.0M | 16.8M | 14.5M | 15.9M |
| 銷售管理費用 | 20.6M | 57.5M | 69.9M | 81.9M | 66.5M | 56.8M | 40.5M | 47.4M | 47.9M | 40.3M | 35.7M | 26.2M |
| 營業利益 | 100M+14% | 81.3M-20% | 77.2M-42% | 43.6M-58% | 88.0M-18% | 102M-26% | 134M+19% | 103M-17% | 107M | 137M | 112M | 124M |
| 營業利益率 | 25.8% | 21.6% | 19.0% | 11.4% | 23.3% | 27.4% | 35.3% | 26.1% | 28.8% | 38.8% | 35.1% | 38.6% |
| 稅後淨利 | 75.0M-5% | 118M+62% | 54.1M-59% | 27.8M-55% | 78.8M-40% | 72.9M-29% | 131M-1% | 62.1M-34% | 131M | 103M | 132M | 94.1M |
| 淨利率 | 19.3% | 31.4% | 13.3% | 7.2% | 20.8% | 19.6% | 34.6% | 15.8% | 35.4% | 29.2% | 41.2% | 29.3% |
| 稀釋 EPS | 1.11-1% | 1.80+76% | 0.86-52% | 0.41-53% | 1.12-40% | 1.02-31% | 1.79-5% | 0.88-34% | 1.87 | 1.48 | 1.88 | 1.33 |
| 稀釋股數 | 67.5M | 65.8M | 68.4M | 67.7M | 70.3M | 71.5M | 73.1M | 70.6M | 70.1M | 70.2M | 70.0M | 71.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 593M | 499M | 359M | 382M | 696M | 939M | 866M | 757M | 718M | 714M | 614M | 414M |
| 應收帳款 | 353M | 356M | 359M | 351M | 337M | 349M | 329M | 372M | 337M | 284M | 259M | 256M |
| 存貨 | 57.6M | 61.3M | 64.7M | 62.0M | 62.2M | 69.1M | 70.8M | 70.5M | 69.8M | 64.0M | 56.5M | 51.8M |
| 總資產 | 2.4B | 2.3B | 2.2B | 2.3B | 2.1B | 2.1B | 2.0B | 1.9B | 1.8B | 1.7B | 1.5B | 1.3B |
| 有息負債 | 570M | 570M | 569M | 568M | 567M | 566M | 613K | 563M | 562M | 562M | 561M | 559M |
| 總負債 | 1.1B | 1.1B | 1.1B | 1.2B | 949M | 891M | 870M | 913M | 886M | 835M | 823M | 785M |
| 股東權益 | 1.3B | 1.2B | 1.1B | 1.1B | 1.2B | 1.2B | 1.2B | 1.0B | 946M | 816M | 699M | 553M |
| 負債比 | 45.7% | 48.3% | 51.1% | 50.8% | 44.9% | 43.4% | 42.4% | 47.1% | 48.4% | 50.6% | 54.1% | 58.7% |
| 淨現金(現金 − 有息負債) | 22.9M | −71.0M | −210M | −186M | 129M | 372M | 866M | 194M | 156M | 152M | 53.6M | −145M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 125M+16% | – | – | – | 108M | – | – | 127M | – | – | – |
| 資本支出 | – | 3.2M | – | – | – | 8.7M | – | – | 8.3M | – | – | – |
| 自由現金流 | – | 122M+23% | – | – | – | 98.8M | – | – | 119M | – | – | – |
| 折舊攤銷 | – | 22.7M | – | – | – | 13.6M | – | – | 15.4M | 39.2M | 2.9M | 3.3M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 32.3% | – | – | – | 26.5% | – | – | 32.2% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 1.5B
| 美國 | 1.5B | 94.6% | -1.7% |
|---|---|---|---|
| 美國以外 | 82.7M | 5.4% | +68.1% |
產品／服務2025 年度 · 3.0B
| PYLARIFY | 989M | 33.0% | -6.5% |
|---|---|---|---|
| Radiopharmaceutical Oncology | 989M | 33.0% | -6.5% |
| Total Precision Diagnostics | 493M | 16.4% | +12.7% |
| Definity | 330M | 11.0% | +3.9% |
| Techne Lite | 86.8M | 2.9% | -9.1% |
| Neuraceq | 51.4M | 1.7% | – |
| Licenseand Royalty Revenues | 34.0M | 1.1% | +272.9% |
| Other Precision Diagnostics | 24.6M | 0.8% | +1.6% |
| 產品 小計 | 1.5B | 50.3% | -1.1% |
| Strategic Partnerships And Other 小計 | 59.4M | 2.0% | +55.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.5B | +0.5% | 234M | 15.2% | 3.41 | 354M |
| FY2024 | 1.5B | +18.3% | 312M | 20.4% | 4.36 | 493M |
| FY2023 | 1.3B | +38.6% | 327M | 25.2% | 4.65 | 260M |
| FY2022 | 935M | +119.9% | 28.1M | 3.0% | 0.40 | 21.8M |
| FY2021 | 425M | +25.3% | −71.3M | -16.8% | -1.06 | 53.9M |
| FY2020 | 339M | -2.3% | −13.5M | -4.0% | -0.25 | 16.4M |
| FY2019 | 347M | +1.2% | 31.7M | 9.1% | 0.79 | 58.3M |
| FY2018 | 343M | – | 40.5M | 11.8% | 1.03 | 41.1M |